Catheter ablation of the cavotricuspid isthmus in patients with atrial flutter: Predictors of long-term outcomes

1Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Background: Predictors of long-term outcomes and an optimal catheter set for ablation of the cavotricuspid isthmus in patients with atrial flutter (AFL) are not well known. Aims: This study aimed to identify predictors of clinical events following ablation. Methods: We studied 741 patients (mean [SD] age, 62.2 [10.8] years; 248 women) who were followed for a mean (SD) time of 4.4 (2.7) years. The 2- versus 3-electrode approach and clinical predictors of clinical events during follow -up were analyzed. Results: The 2-electrode approach was faster (mean [SD] time, 62.5 [30.3] vs 101.4 [51] min; P <0.001), associated with shorter fluoroscopy time (13.1 [9.3] vs 20.3 [12.4] min; P < 0.001), cost-effective (8.29 [2.82] vs 11.89 [2.51] units; P <0.001), and more effective (92.1% vs 86.1%; P = 0.012). The independent predictors of AFL recurrence were: calcium blocker use (hazard ratio [HR], 3.24; 95% CI, 1.64-6.4), mitral valve disease (HR, 1.82; 95% CI, 1.12-2.95), previous stroke and / or TIA (HR, 2.38; 95% CI, 1.21-4.65), pulmonary artery dilatation (HR, 3.94; 95% CI, 1.22-12.73), and previous pulmonary embolism (HR, 3.77; 95% CI, 1.14-12.43); of atrial fibrillation (AF): previous AF (HR, 6.054; 95% CI, 4.58-8), left atrial enlargement (HR, 1.43; 95% CI, 1.12-1.81), number of antiarrhythmic drugs used (HR, 1.16; 95% CI, 1.05-1.28), and mitral valve disease (HR, 1.28; 95% CI, 1.04-1.58); of pacemaker implantation: tachycardia-bradycardia syndrome (HR, 6.17; 95% CI, 3.16-12.05), previous second-/third-degree atrioventricular block (HR, 29.4; 95% CI, 7.37-117.28), centrally acting hypotensive drugs (HR, 29.55; 95% CI, 6.14-142.25), aortic dilatation or aneurysm (HR, 2.58; 95% CI, 1.06-6.3), a labile international normalized ratio (HR, 3.45; 95% CI, 1.72-6.93), left bundle branch block (HR, 4.7; 95% CI, 1.49-14.82), the shortest R-R interval during AFL (HR, 1.003; 95% CI, 1.001-1.005), previous cardiac surgery (HR, 2.69; 95% CI, 1.27-5.7), and aortic valve disease (HR, 2.22; 95% CI, 1.08-4.59). Conclusions: Ablation of cavotricuspid isthmus with a minimal number of electrodes is safe and effective. Specific predictors of clinical events during long-term follow-up can be determined.

References Powered by Scopus

Incidence and predictors of atrial flutter in the general population

282Citations
N/AReaders
Get full text

Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: A meta-analysis

250Citations
N/AReaders
Get full text

Risk for permanent pacemaker after transcatheter aortic valve implantation: A comprehensive analysis of the literature

202Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Antithrombotic therapy in atrial flutter: To anticoagulate or not, that is the question

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Dudek, K., Futyma, P., Futyma, M., Stec, S., & Kułakowski, P. (2020). Catheter ablation of the cavotricuspid isthmus in patients with atrial flutter: Predictors of long-term outcomes. Kardiologia Polska, 78(78), 741–749. https://doi.org/10.33963/KP.15408

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Researcher 2

40%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

86%

Environmental Science 1

14%

Save time finding and organizing research with Mendeley

Sign up for free